Academic Journal
View in EDS
Linked Full Text

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study

Bibliographic Details
Title: Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
Authors: Nico C. Grossmann, Pawel Rajwa, Fahad Quhal, Frederik König, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Satoshi Katayama, Reza Sari Motlagh, Christian D. Fankhauser, Agostino Mattei, Marco Moschini, Piotr Chlosta, Bas W.G. van Rhijn, Jeremy Y.C. Teoh, Eva Compérat, Marek Babjuk, Mohammad Abufaraj, Pierre I. Karakiewicz, Shahrokh F. Shariat, Benjamin Pradere
Source: European Urology Open Science, Vol 39, Iss , Pp 14-21 (2022)
Publisher Information: Elsevier, 2022.
Publication Year: 2022
Collection: LCC:Diseases of the genitourinary system. Urology
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Urinary bladder neoplasms, Mycobacterium bovis, Recurrence, Disease progression, Survival, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Background: Radical cystectomy (RC) is indicated in primary or secondary muscle-invasive bladder cancer (primMIBC, secMIBC) and in primary or recurrent high- or very high-risk non–muscle-invasive bladder cancer (primHR-NMIBC, recHR-NMIBC). The optimal timing for RC along the disease spectrum of nonmetastatic urothelial carcinoma remains unclear. Objective: To compare outcomes after RC between patients with primHR-NMIBC, recHR-NMIBC, primMIBC, and secMIBC. Design, setting, and participants: This retrospective, multicenter study included patients with clinically nonmetastatic bladder cancer (BC) treated with RC. Outcome measurements and statistical analysis: We assessed oncological outcomes for patients who underwent RC according to the natural history of their BC. primHR-NMIBC and primMIBC were defined as no prior history of BC, and recHR-NMIBC and secMIBC as previously treated NMIBC that recurred or progressed to MIBC, respectively. Log-rank analysis was used to compare survival outcomes, and univariable and multivariable Cox and logistic regression analyses were used to identify predictors for survival. Results and limitations: Among the 908 patients included, 211 (23%) had primHR-NMIBC, 125 (14%) had recHR-NMIBC, 404 (44%) had primMIBC, and 168 (19%) had secMIBC. Lymph node involvement and pathological upstaging were more frequent in the secMIBC group than in the other groups (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2666-1683
Relation: http://www.sciencedirect.com/science/article/pii/S2666168322000544; https://doaj.org/toc/2666-1683
DOI: 10.1016/j.euros.2022.02.011
Access URL: https://doaj.org/article/c62fcc5d2989460aaaecd0f907a886be
Accession Number: edsdoj.62fcc5d2989460aaaecd0f907a886be
Database: Directory of Open Access Journals
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4173B0D49AE2EA4F40DE&Show=Object
Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/j.euros.2022.02.011?
    Name: ScienceDirect (all content)-s8985755
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=26661683&ISBN=&volume=39&issue=14-21&date=20220501&spage=14&pages=14-21&title=European Urology Open Science&atitle=Comparative%20Outcomes%20of%20Primary%20Versus%20Recurrent%20High-risk%20Non%E2%80%93muscle-invasive%20and%20Primary%20Versus%20Secondary%20Muscle-invasive%20Bladder%20Cancer%20After%20Radical%20Cystectomy%3A%20Results%20from%20a%20Retrospective%20Multicenter%20Study&aulast=Nico%20C.%20Grossmann&id=DOI:10.1016/j.euros.2022.02.011
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/c62fcc5d2989460aaaecd0f907a886be
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.62fcc5d2989460aaaecd0f907a886be
RelevancyScore: 967
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 967.376770019531
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nico+C%2E+Grossmann%22">Nico C. Grossmann</searchLink><br /><searchLink fieldCode="AR" term="%22Pawel+Rajwa%22">Pawel Rajwa</searchLink><br /><searchLink fieldCode="AR" term="%22Fahad+Quhal%22">Fahad Quhal</searchLink><br /><searchLink fieldCode="AR" term="%22Frederik+König%22">Frederik König</searchLink><br /><searchLink fieldCode="AR" term="%22Hadi+Mostafaei%22">Hadi Mostafaei</searchLink><br /><searchLink fieldCode="AR" term="%22Ekaterina+Laukhtina%22">Ekaterina Laukhtina</searchLink><br /><searchLink fieldCode="AR" term="%22Keiichiro+Mori%22">Keiichiro Mori</searchLink><br /><searchLink fieldCode="AR" term="%22Satoshi+Katayama%22">Satoshi Katayama</searchLink><br /><searchLink fieldCode="AR" term="%22Reza+Sari+Motlagh%22">Reza Sari Motlagh</searchLink><br /><searchLink fieldCode="AR" term="%22Christian+D%2E+Fankhauser%22">Christian D. Fankhauser</searchLink><br /><searchLink fieldCode="AR" term="%22Agostino+Mattei%22">Agostino Mattei</searchLink><br /><searchLink fieldCode="AR" term="%22Marco+Moschini%22">Marco Moschini</searchLink><br /><searchLink fieldCode="AR" term="%22Piotr+Chlosta%22">Piotr Chlosta</searchLink><br /><searchLink fieldCode="AR" term="%22Bas+W%2EG%2E+van+Rhijn%22">Bas W.G. van Rhijn</searchLink><br /><searchLink fieldCode="AR" term="%22Jeremy+Y%2EC%2E+Teoh%22">Jeremy Y.C. Teoh</searchLink><br /><searchLink fieldCode="AR" term="%22Eva+Compérat%22">Eva Compérat</searchLink><br /><searchLink fieldCode="AR" term="%22Marek+Babjuk%22">Marek Babjuk</searchLink><br /><searchLink fieldCode="AR" term="%22Mohammad+Abufaraj%22">Mohammad Abufaraj</searchLink><br /><searchLink fieldCode="AR" term="%22Pierre+I%2E+Karakiewicz%22">Pierre I. Karakiewicz</searchLink><br /><searchLink fieldCode="AR" term="%22Shahrokh+F%2E+Shariat%22">Shahrokh F. Shariat</searchLink><br /><searchLink fieldCode="AR" term="%22Benjamin+Pradere%22">Benjamin Pradere</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: European Urology Open Science, Vol 39, Iss , Pp 14-21 (2022)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Elsevier, 2022.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2022
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Diseases of the genitourinary system. Urology<br />LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Urinary+bladder+neoplasms%22">Urinary bladder neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Mycobacterium+bovis%22">Mycobacterium bovis</searchLink><br /><searchLink fieldCode="DE" term="%22Recurrence%22">Recurrence</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+progression%22">Disease progression</searchLink><br /><searchLink fieldCode="DE" term="%22Survival%22">Survival</searchLink><br /><searchLink fieldCode="DE" term="%22Diseases+of+the+genitourinary+system%2E+Urology%22">Diseases of the genitourinary system. Urology</searchLink><br /><searchLink fieldCode="DE" term="%22RC870-923%22">RC870-923</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Background: Radical cystectomy (RC) is indicated in primary or secondary muscle-invasive bladder cancer (primMIBC, secMIBC) and in primary or recurrent high- or very high-risk non–muscle-invasive bladder cancer (primHR-NMIBC, recHR-NMIBC). The optimal timing for RC along the disease spectrum of nonmetastatic urothelial carcinoma remains unclear. Objective: To compare outcomes after RC between patients with primHR-NMIBC, recHR-NMIBC, primMIBC, and secMIBC. Design, setting, and participants: This retrospective, multicenter study included patients with clinically nonmetastatic bladder cancer (BC) treated with RC. Outcome measurements and statistical analysis: We assessed oncological outcomes for patients who underwent RC according to the natural history of their BC. primHR-NMIBC and primMIBC were defined as no prior history of BC, and recHR-NMIBC and secMIBC as previously treated NMIBC that recurred or progressed to MIBC, respectively. Log-rank analysis was used to compare survival outcomes, and univariable and multivariable Cox and logistic regression analyses were used to identify predictors for survival. Results and limitations: Among the 908 patients included, 211 (23%) had primHR-NMIBC, 125 (14%) had recHR-NMIBC, 404 (44%) had primMIBC, and 168 (19%) had secMIBC. Lymph node involvement and pathological upstaging were more frequent in the secMIBC group than in the other groups (p
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2666-1683
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: http://www.sciencedirect.com/science/article/pii/S2666168322000544; https://doaj.org/toc/2666-1683
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1016/j.euros.2022.02.011
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/c62fcc5d2989460aaaecd0f907a886be" linkWindow="_blank">https://doaj.org/article/c62fcc5d2989460aaaecd0f907a886be</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.62fcc5d2989460aaaecd0f907a886be
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.62fcc5d2989460aaaecd0f907a886be
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euros.2022.02.011
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 14
    Subjects:
      – SubjectFull: Urinary bladder neoplasms
        Type: general
      – SubjectFull: Mycobacterium bovis
        Type: general
      – SubjectFull: Recurrence
        Type: general
      – SubjectFull: Disease progression
        Type: general
      – SubjectFull: Survival
        Type: general
      – SubjectFull: Diseases of the genitourinary system. Urology
        Type: general
      – SubjectFull: RC870-923
        Type: general
      – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
        Type: general
      – SubjectFull: RC254-282
        Type: general
    Titles:
      – TitleFull: Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nico C. Grossmann
      – PersonEntity:
          Name:
            NameFull: Pawel Rajwa
      – PersonEntity:
          Name:
            NameFull: Fahad Quhal
      – PersonEntity:
          Name:
            NameFull: Frederik König
      – PersonEntity:
          Name:
            NameFull: Hadi Mostafaei
      – PersonEntity:
          Name:
            NameFull: Ekaterina Laukhtina
      – PersonEntity:
          Name:
            NameFull: Keiichiro Mori
      – PersonEntity:
          Name:
            NameFull: Satoshi Katayama
      – PersonEntity:
          Name:
            NameFull: Reza Sari Motlagh
      – PersonEntity:
          Name:
            NameFull: Christian D. Fankhauser
      – PersonEntity:
          Name:
            NameFull: Agostino Mattei
      – PersonEntity:
          Name:
            NameFull: Marco Moschini
      – PersonEntity:
          Name:
            NameFull: Piotr Chlosta
      – PersonEntity:
          Name:
            NameFull: Bas W.G. van Rhijn
      – PersonEntity:
          Name:
            NameFull: Jeremy Y.C. Teoh
      – PersonEntity:
          Name:
            NameFull: Eva Compérat
      – PersonEntity:
          Name:
            NameFull: Marek Babjuk
      – PersonEntity:
          Name:
            NameFull: Mohammad Abufaraj
      – PersonEntity:
          Name:
            NameFull: Pierre I. Karakiewicz
      – PersonEntity:
          Name:
            NameFull: Shahrokh F. Shariat
      – PersonEntity:
          Name:
            NameFull: Benjamin Pradere
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 26661683
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 14-21
          Titles:
            – TitleFull: European Urology Open Science
              Type: main
ResultId 1